ESMO 2024 Insights: SUNNIFORECAST Trial - Nivo + Ipi vs. Standard of Care in Non-Clear-Cell RCCs

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: SUNNIFORECAST Trial - Nivo + Ipi vs. Standard of Care in Non-Clear-Cell RCCs

By ecancer FEATURING Lothar Bergmann

10 views

October 16, 2024

Comments 0

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

Feat. R. Alter, A. Rezazadeh

2024 ESMO Annual Meeting Insights Hub: GU Videos

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

236 views

3 weeks ago

ESMO 2024 Summary: Practice-Changing Trials for Patients With Locali…

2024 ESMO Annual Meeting Insights Hub

P. Grivas

245 views

2 months ago

ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la…

2024 ESMO Annual Meeting Insights Hub

E. Plimack

173 views

1 month ago

View All

APCCC 2026

Fri, Feb 27, 2026

RENALC-BLADDR-PROSCA 2024

RENALC 2024 - Hybrid Global Forum on GU Oncology

Tue, Nov 26, 2024

See 1 other

RENALC-BLADDR-PROSCA 2024

PROSCA 2024 - Hybrid Global Forum on GU Oncology

Thu, Nov 28, 2024

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Insights from 2024 ASCO® GU Annual Meeting

E. Efstathiou

2.6K views

9 months ago

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views

8 months ago

Bladder Cancer Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

1.4K views

5 months ago

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

7 months ago

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

7 months ago

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

Yale Cancer Center

I. Kim

432 views

1 month ago

AUA Advanced Prostate Cancer Guidelines: 2023 Update

Robert Dreicer

1.3K views

11 months ago

Testosterone Suppression and Recovery in Patients With Advanced Pros…

Benjamin L. Maughan

661 views

5 months ago

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

SIR 2023 Conference Coverage

N. Kothary

3.0K views

1 year ago

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

2024 ESMO Annual Meeting Insights Hub

R. Dreicer

276 views

1 month ago

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers

529 views

8 months ago

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

2024 ASCO® Annual Meeting Insights Hub

K. Mittal

364 views

4 months ago

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Or…

2024 ASCO® Annual Meeting Insights Hub

J. Hafron

643 views

5 months ago

Opus One: Final Results - RFA in Axial Skeleton

Jason Levy

2.0K views

1 year ago

New

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

178 views

2 weeks ago

New

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

Penn Medicine Abramson Cancer Center

D. Lee

194 views

1 week ago

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

236 views

3 weeks ago

Urothelial Carcinoma: New Developments

Weill Cornell Medicine Oncology & Hematology

C. Sternberg

344 views

5 months ago

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

University of Colorado Cancer Center

T. Flaig

337 views

6 months ago

ASCO® 2024 Summary: "Bladder and RCC Highlights"

2024 ASCO® Annual Meeting Insights Hub

K. Tawagi, N. Reizine

263 views

4 months ago

AUTOPLAY

Login

Login

Join VuMedi

ESMO 2024 Insights: SUNNIFORECAST Trial - Nivo + Ipi vs. Standard of Care in Non-Clear-Cell RCCs

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma and Qual…

2024 ESMO Annual Meeting Insights Hub: GU Videos

ESMO 2024 Summary: Developmental Therapeutics Highlights

ESMO 2024 Summary: Practice-Changing Trials for Patients With Locali…

ESMO 2024 Summary: Important GU Trials - EV-103 5-Year Follow-Up (la…

Recommended

APCCC 2026

RENALC 2024 - Hybrid Global Forum on GU Oncology

PROSCA 2024 - Hybrid Global Forum on GU Oncology

ASCO® GU 2024 Summary: "Important Prostate Cancer Take-Home Messages"

Recent GU Developments and Their Clinical Implications

Bladder Cancer Highlights From ASCO® 2024

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Hyperprogression in Cancer Treated With Immunotherapy

Surgical Management of High-Risk and Locally Advanced Prostate Cancer

AUA Advanced Prostate Cancer Guidelines: 2023 Update

Testosterone Suppression and Recovery in Patients With Advanced Pros…

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

ESMO 2024 Summary: GU Practice-Changing Trial Results of PEACE-3 (mC…

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

ASCO® 2024 Insights: "Evaluation of Persistence and Adherence for Or…

Opus One: Final Results - RFA in Axial Skeleton

Visible vs. Invisible Cancers - The Genomics and Natural History

Enhanced Diagnostics in Prostate Cancer: PSA and Beyond in 2024

ESMO 2024 Summary: Developmental Therapeutics Highlights

Urothelial Carcinoma: New Developments

NCCN Guidelines Updates for the Treatment of Metastatic Urothelial C…

ASCO® 2024 Summary: "Bladder and RCC Highlights"